Logo image of DH

DEFINITIVE HEALTHCARE CORP (DH) Stock Fundamental Analysis

NASDAQ:DH - Nasdaq - US24477E1038 - Common Stock - Currency: USD

2.85  +0.22 (+8.37%)

After market: 2.85 0 (0%)

Fundamental Rating

4

Overall DH gets a fundamental rating of 4 out of 10. We evaluated DH against 37 industry peers in the Health Care Technology industry. While DH seems to be doing ok healthwise, there are quite some concerns on its profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on DH.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

DH had positive earnings in the past year.
In the past year DH had a positive cash flow from operations.
DH had negative earnings in each of the past 5 years.
Each year in the past 5 years DH had a positive operating cash flow.
DH Yearly Net Income VS EBIT VS OCF VS FCFDH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

DH has a Return On Assets of -37.92%. This is comparable to the rest of the industry: DH outperforms 43.24% of its industry peers.
DH's Return On Equity of -92.97% is in line compared to the rest of the industry. DH outperforms 40.54% of its industry peers.
Industry RankSector Rank
ROA -37.92%
ROE -92.97%
ROIC N/A
ROA(3y)-16.45%
ROA(5y)-10.62%
ROE(3y)-39.07%
ROE(5y)-24.71%
ROIC(3y)N/A
ROIC(5y)N/A
DH Yearly ROA, ROE, ROICDH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

Looking at the Gross Margin, with a value of 78.30%, DH belongs to the top of the industry, outperforming 86.49% of the companies in the same industry.
In the last couple of years the Gross Margin of DH has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for DH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y0.01%
DH Yearly Profit, Operating, Gross MarginsDH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

DH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DH has been reduced compared to 1 year ago.
The number of shares outstanding for DH has been increased compared to 5 years ago.
DH has a worse debt/assets ratio than last year.
DH Yearly Shares OutstandingDH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DH Yearly Total Debt VS Total AssetsDH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

DH has an Altman-Z score of 0.01. This is a bad value and indicates that DH is not financially healthy and even has some risk of bankruptcy.
DH's Altman-Z score of 0.01 is in line compared to the rest of the industry. DH outperforms 48.65% of its industry peers.
The Debt to FCF ratio of DH is 5.30, which is a neutral value as it means it would take DH, 5.30 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DH (5.30) is better than 64.86% of its industry peers.
DH has a Debt/Equity ratio of 0.52. This is a neutral value indicating DH is somewhat dependend on debt financing.
DH's Debt to Equity ratio of 0.52 is on the low side compared to the rest of the industry. DH is outperformed by 64.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 5.3
Altman-Z 0.01
ROIC/WACCN/A
WACC10.25%
DH Yearly LT Debt VS Equity VS FCFDH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

DH has a Current Ratio of 2.30. This indicates that DH is financially healthy and has no problem in meeting its short term obligations.
DH has a better Current ratio (2.30) than 67.57% of its industry peers.
A Quick Ratio of 2.30 indicates that DH has no problem at all paying its short term obligations.
DH has a better Quick ratio (2.30) than 67.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.3
Quick Ratio 2.3
DH Yearly Current Assets VS Current LiabilitesDH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.67% over the past year.
Looking at the last year, DH shows a small growth in Revenue. The Revenue has grown by 0.31% in the last year.
Measured over the past years, DH shows a very strong growth in Revenue. The Revenue has been growing by 24.15% on average per year.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
Revenue 1Y (TTM)0.31%
Revenue growth 3Y14.91%
Revenue growth 5Y24.15%
Sales Q2Q%-5.52%

3.2 Future

Based on estimates for the next years, DH will show a decrease in Earnings Per Share. The EPS will decrease by -2.01% on average per year.
Based on estimates for the next years, DH will show a small growth in Revenue. The Revenue will grow by 0.85% on average per year.
EPS Next Y-13.07%
EPS Next 2Y-2.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.91%
Revenue Next 2Y-1.44%
Revenue Next 3Y0.85%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DH Yearly Revenue VS EstimatesDH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
DH Yearly EPS VS EstimatesDH Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.14, which indicates a very decent valuation of DH.
Based on the Price/Earnings ratio, DH is valued cheaper than 100.00% of the companies in the same industry.
DH is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
DH is valuated reasonably with a Price/Forward Earnings ratio of 9.37.
Based on the Price/Forward Earnings ratio, DH is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
DH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 8.14
Fwd PE 9.37
DH Price Earnings VS Forward Price EarningsDH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DH indicates a rather cheap valuation: DH is cheaper than 97.30% of the companies listed in the same industry.
91.89% of the companies in the same industry are more expensive than DH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.47
EV/EBITDA 4.82
DH Per share dataDH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

DH's earnings are expected to decrease with -2.01% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.01%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DEFINITIVE HEALTHCARE CORP

NASDAQ:DH (3/7/2025, 8:19:41 PM)

After market: 2.85 0 (0%)

2.85

+0.22 (+8.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners36.9%
Inst Owner Change-0.65%
Ins Owners3.25%
Ins Owner Change34.27%
Market Cap434.03M
Analysts74.55
Price Target5 (75.44%)
Short Float %4.58%
Short Ratio2.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.74%
Min EPS beat(2)9.63%
Max EPS beat(2)21.86%
EPS beat(4)3
Avg EPS beat(4)6.85%
Min EPS beat(4)-4.79%
Max EPS beat(4)21.86%
EPS beat(8)6
Avg EPS beat(8)16.57%
EPS beat(12)10
Avg EPS beat(12)22.91%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.78%
Min Revenue beat(2)-1.38%
Max Revenue beat(2)-0.19%
Revenue beat(4)0
Avg Revenue beat(4)-1.84%
Min Revenue beat(4)-3.69%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.75%
Revenue beat(12)2
Avg Revenue beat(12)-1.32%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.67%
PT rev (3m)-7.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.93%
EPS NY rev (1m)0.26%
EPS NY rev (3m)-2.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.23%
Revenue NY rev (1m)-2.26%
Revenue NY rev (3m)-2.27%
Valuation
Industry RankSector Rank
PE 8.14
Fwd PE 9.37
P/S 1.72
P/FCF 9.47
P/OCF 7.46
P/B 0.98
P/tB N/A
EV/EBITDA 4.82
EPS(TTM)0.35
EY12.28%
EPS(NY)0.3
Fwd EY10.68%
FCF(TTM)0.3
FCFY10.56%
OCF(TTM)0.38
OCFY13.41%
SpS1.66
BVpS2.92
TBVpS-1.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.92%
ROE -92.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.3%
FCFM 18.18%
ROA(3y)-16.45%
ROA(5y)-10.62%
ROE(3y)-39.07%
ROE(5y)-24.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y0.01%
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 5.3
Debt/EBITDA 5.47
Cap/Depr 23.89%
Cap/Sales 4.89%
Interest Coverage N/A
Cash Conversion 138.81%
Profit Quality N/A
Current Ratio 2.3
Quick Ratio 2.3
Altman-Z 0.01
F-Score4
WACC10.25%
ROIC/WACCN/A
Cap/Depr(3y)14.76%
Cap/Depr(5y)11.57%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
EPS Next Y-13.07%
EPS Next 2Y-2.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.31%
Revenue growth 3Y14.91%
Revenue growth 5Y24.15%
Sales Q2Q%-5.52%
Revenue Next Year-5.91%
Revenue Next 2Y-1.44%
Revenue Next 3Y0.85%
Revenue Next 5YN/A
EBIT growth 1Y68.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-5.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.99%
FCF growth 3Y35.38%
FCF growth 5Y18.42%
OCF growth 1Y41.29%
OCF growth 3Y32.16%
OCF growth 5Y21.93%